study_nr,author,title,pubyear,invivo_exvivo,invivo_exvivo_nr,structures_names,structures_nr,ident_seg,ident_seg_nr,Manual_or_Automatic_segmentation,manseg_auto_seg_nr,Which_sequence_visible,sequence_nr,Field_strength,Field_strength_nr,control_patient,type_of_patient,Total_n,T1_x,T1_y,T1_z,T1_voxel_volume_cubic_mm,T2_x,T2_y,T2_z,T2_voxel_volume_cubic_mm,T2s_x,T2s_y,T2s_z,T2s_voxel_volume_cubic_mm,fT2s_x,fT2s_y,fT2s_z,fT2s_voxel_volume_cubic_mm,dwi_x,dwi_y,dwi_z,dwi_voxel_volume_cubic_mm,swi_x,swi_y,swi_z,swi_voxel_volume_cubic_mm,mt_x,mt_y,mt_z,mt_voxel_volume_cubic_mm,pd_x,pd_y,pd_z,pd_voxel_volume_cubic_mm,other_x,other_y,other_z,other_voxel_volume_cubic_mm
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,globus pallidus,13,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,caudate,17,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,putamen,19,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,red nucleus,91,Identification,1,NA,0,GE Magnitude PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,red nucleus,91,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,medullary lamella of the red nucleus,94,Identification,1,NA,0,GE Magnitude PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,medullary lamella of the red nucleus,94,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,red nucleus pars oralis,95,Identification,1,NA,0,GE Magnitude PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,red nucleus pars oralis,95,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,red nucleus pars dorsomedialis,96,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,substantia nigra pars dorsalis,108,Identification,1,NA,0,GE Magnitude PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,substantia nigra pars dorsalis,108,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,substantia nigra pars lateralis,109,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,substantia nigra matrix,111,Identification,1,NA,0,GE Magnitude PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,substantia nigra matrix,111,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
1,Abduljalil,Enhanced Gray and White Matter Contrast of Phase Susceptibility-Weighted Images in Ultra-High-Field Magnetic Resonance Imaging ,2003,Invivo,1,thalamus,115,Identification,1,NA,0,GE Phase PD/T2*,9,8.0,2,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.391,0.391,5,0.764405
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,basal ganglia,12,Identification,1,NA,0,SE T2,2,7.0,1,1,0,6,NA,NA,NA,NA,0.375,0.375,2,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,globus pallidus,13,Segmentation,2,n.s.,9999,SE T2,2,7.0,1,1,0,6,NA,NA,NA,NA,0.375,0.375,2,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,globus pallidus external segment,15,Identification,1,NA,0,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,red nucleus,91,Segmentation,2,n.s.,9999,SE T2,2,7.0,1,1,0,6,NA,NA,NA,NA,0.375,0.375,2,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,substantia nigra,104,Segmentation,2,n.s.,9999,SE T2,2,7.0,1,1,0,6,NA,NA,NA,NA,0.375,0.375,2,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,subthalamic nucleus,112,Segmentation,2,n.s.,9999,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,subthalamic nucleus,112,Segmentation,2,n.s.,9999,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,subthalamic nucleus,112,Segmentation,2,n.s.,9999,SE T2,2,7.0,1,1,0,6,NA,NA,NA,NA,0.375,0.375,2,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,thalamus,115,Identification,1,NA,0,SE T2,2,7.0,1,1,0,6,NA,NA,NA,NA,0.375,0.375,2,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,pulvinar,136,Identification,1,NA,0,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,thalamus ventral caudalis,139,Identification,1,NA,0,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Abosch,An Assessment of Current Brain Targets for Deep Brain Stimulation Surgery With Susceptibility-Weighted Imaging at 7 Tesla ,2010,Invivo,1,thalamus ventral intermediate nucleus,143,Identification,1,NA,0,GE SWI,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.67,0.67,0.67,0.300763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,abducens nucleus,1,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,abducens nucleus,1,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,dorsal accessory olivary nucleus,26,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,facial motor nucleus,30,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,hypoglossal nucleus,40,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,inferior olivary nucleus,49,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,inferior olivary nucleus,49,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,lateral vestibular nucleus,50,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,medial accessory olivary nucleus,54,Identification,1,NA,0,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,medial accessory olivary nucleus,54,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,cuneatus nucleus,58,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,lateral cuneatus nucleus,59,Identification,1,NA,0,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,oculomotor nucleus,64,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,primary olivary nucleus,76,Segmentation,2,n.s.,9999,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,primary sensory nucleus of trigeminal nerve,77,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,pontine nuclei,83,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,raphe nuclei,84,Identification,1,NA,0,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,dorsal raphe R1,86,Identification,1,NA,0,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,superior olivary nucleus,113,Identification,1,NA,0,ADC 0.170mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.17,0.17,0.004913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,trigeminal motor nucleus,147,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Aggarwal,Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7 T ,2013,Exvivo,2,trochlear nucleus,148,Segmentation,2,n.s.,9999,ADC 0.255mm,5,11.7,4,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,0.125,0.125,0.001953125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Al_Helli,Deep brain stimulation of the subthalamic nucleus: histological verification and 9.4-T MRI correlation ,2015,Exvivo,2,subthalamic nucleus,112,Identification,1,NA,0,FSE,2,9.4,3,2,1,1,NA,NA,NA,NA,0.234,0.234,0.5,0.027378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Al_Radaideh,Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome ,2012,Invivo,1,globus pallidus,13,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,3,2,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Al_Radaideh,Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome ,2012,Invivo,1,caudate,17,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,3,2,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Al_Radaideh,Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome ,2012,Invivo,1,putamen,19,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,3,2,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Al_Radaideh,Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome ,2012,Invivo,1,thalamus minus pulvinar,134,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,3,2,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Al_Radaideh,Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome ,2012,Invivo,1,pulvinar,136,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,3,2,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,globus pallidus internal segment,14,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,globus pallidus external segment,15,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,caudate,17,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,putamen,19,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,claustrum,23,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,red nucleus,91,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,substantia innominata,103,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,substantia nigra,104,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,subthalamic nucleus,112,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,anterior thalamic nucleus,116,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,anterior thalamic nucleus,116,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Alarcon,Anatomic Study of the Central Core of the Cerebrum Correlating 7-T Magnetic Resonance Imaging and Fiber Dissection With the Aid of a Neuronavigation System ,2014,Exvivo,2,zona incerta,151,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,1,0,5,0.33,0.33,1,0.1089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
7,Alkemade,Comparison of T2s weighted and qsm contrast in parkinsons disease to visualize the stn with MRI,2017,invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T2s and qsm,8,7.0,1,3,1,24,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Augustinack,H.M.s Contributions to Neuroscience: A Review and Autopsy Studies ,2014,Exvivo,2,mammillary body,53,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,2,5,1,0.21,0.21,0.21,0.009261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Augustinack,H.M.s Contributions to Neuroscience: A Review and Autopsy Studies ,2014,Exvivo,2,red nucleus,91,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,2,5,1,0.21,0.21,0.21,0.009261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Augustinack,H.M.s Contributions to Neuroscience: A Review and Autopsy Studies ,2014,Exvivo,2,substantia nigra,104,Identification,1,NA,0,T1NAweigthed FLASH,1,7.0,1,2,5,1,NA,NA,NA,NA,NA,NA,NA,NA,0.21,0.21,0.21,0.009261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Bao,QSM using structural feature based collaborative reconstruction in the human brain,2017,Invivo,1,caudate,17,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.98,0.98,0.98,0.94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Bao,QSM using structural feature based collaborative reconstruction in the human brain,2017,Invivo,1,putamen,19,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.98,0.98,0.98,0.94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Bao,QSM using structural feature based collaborative reconstruction in the human brain,2017,Invivo,1,globus pallidus,13,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.98,0.98,0.98,0.94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Bao,QSM using structural feature based collaborative reconstruction in the human brain,2017,Invivo,1,substantia nigra,104,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.98,0.98,0.98,0.94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Bao,QSM using structural feature based collaborative reconstruction in the human brain,2017,Invivo,1,red nucleus,91,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.98,0.98,0.98,0.94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
10,Barry,On the Origins of Signal Variance in FMRI of the Human Midbrain at High Field ,2013,Invivo,1,midbrain,57,Segmentation,2,Manual,1,Magnitude Restrospective Cardiac gating ,3,7.0,1,1,0,26,NA,NA,NA,NA,NA,NA,NA,NA,1,0.99,5,4.95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
10,Barry,On the Origins of Signal Variance in FMRI of the Human Midbrain at High Field ,2013,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,Magnitude Restrospective Cardiac gating ,3,7.0,1,1,0,26,NA,NA,NA,NA,NA,NA,NA,NA,1,0.99,5,4.95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
10,Barry,On the Origins of Signal Variance in FMRI of the Human Midbrain at High Field ,2013,Invivo,1,ventral tegmental area,150,Segmentation,2,Manual,1,Magnitude Restrospective Cardiac gating ,3,7.0,1,1,0,26,NA,NA,NA,NA,NA,NA,NA,NA,1,0.99,5,4.95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Batson,Single session imaging of cerebellum at 7T-obstaining structure and function of multiple motor subsystems in individual subjects,2015,Invivo,1,dentate nucleus,25,Identification,1,NA,0,T2,2,7.0,1,1,0,7,NA,NA,NA,NA,0.28,0.28,4,0.3136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Batson,Single session imaging of cerebellum at 7T-obstaining structure and function of multiple motor subsystems in individual subjects,2015,Invivo,1,fastigial nucleus,21,Identification,1,NA,0,T2,2,7.0,1,1,0,7,NA,NA,NA,NA,0.28,0.28,4,0.3136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Batson,Single session imaging of cerebellum at 7T-obstaining structure and function of multiple motor subsystems in individual subjects,2015,Invivo,1,interposed nucleus,20,Identification,1,NA,0,T2,2,7.0,1,1,0,7,NA,NA,NA,NA,0.28,0.28,4,0.3136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,caudate,17,Segmentation,2,Automatic,4,T1 MPRAGE,1,7.0,1,1,0,40,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,putamen,19,Segmentation,2,Automatic,4,T1 MPRAGE,1,7.0,1,1,0,40,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,globus pallidus,13,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,amygdala,3,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,thalamus,115,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,red nucleus,91,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,substantia nigra,104,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,globus pallidus internal segment,14,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Betts,High-resolution characterisation of the agin brain uses simultaneous qsm and r2s measurements at 7T,2017,invivo,1,globus pallidus external segment,15,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,1.6,1.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,dorsal nucleus of the vagal nerve,29,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,hypoglossal nucleus,40,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,inferior olivary nucleus,49,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,medial accessory olivary nucleus,54,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,cuneatus nucleus,58,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,gracil nucleus,60,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,solitary nucleus,63,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,olivary complex,66,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,spinal nucleus of the trigeminal nerve,101,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
13,Beuls,Microanatomy of the excised human spinal cord and the cervicomedullary junction examined with high-resolution MR imaging at 9.4 Tesla,1993,Exvivo,2,substantia gelatinosa,102,Identification,1,NA,0,PD,8,9.4,3,9999,9999,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,medula oblongata,11,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,choroid plexus,22,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,dentate nucleus,25,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,inferior olivary nucleus,49,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,cuneatus nucleus,58,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,gracil nucleus,60,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Beuls,The Arnold-Chiari Type II Malformation at Midgestation ,2003,Exvivo,2,pons,79,Identification,1,NA,0,T2,2,9.4,3,3,7,2,NA,NA,NA,NA,0.04,0.04,1,0.0016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,inferior olivary nucleus,49,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,mesencephalic tegmental nuclei,55,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,periaqueductal gray,68,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,pontine nuclei,83,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,raphe nuclei,84,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,raphne magnus,85,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,substantia nigra pars compacta,105,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,substantia nigra pars reticularis,110,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Bianciardi ,Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal. Autonomic. and Motor Systems ,2015,Invivo,1,subthalamic nucleus,112,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Bianciardi ,A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI,2017,Invivo,1,cuneatus nucleus,58,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Bianciardi ,A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI,2017,Invivo,1,pedunculotegmental nucleus,154,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Bianciardi ,A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI,2017,Invivo,1,oral pontine reticular nucleus,155,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Bianciardi ,A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI,2017,Invivo,1,paramedian raphe,156,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Bianciardi ,A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI,2017,Invivo,1,caudal linear raphe,157,Segmentation,2,Semi automatic,3,DTI FA & T2,10,7.0,1,1,0,12,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
17,Blazejewska,Visualization of nigrosome 1 and its loss in PD pathoanatomical correlation and in vivo 7 T MR,2011,Invivo,1,substantia nigra,104,Identification,1,NA,0,T2* and MTNAT1,10,7.0,1,3,1,2,0.6,0.6,0.6,0.216,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
17,Blazejewska,Visualization of nigrosome 1 and its loss in PD pathoanatomical correlation and in vivo 7 T MR,2011,Exvivo,2,substantia nigra,104,Identification,1,NA,0,T2* and MTNAT1,10,7.0,1,3,1,3,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Blazejewska,Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome a 7 Tesla MRI study,2015,Invivo,1,red nucleus,91,Identification,1,NA,0,3D T2* GRE,3,7.0,1,3,2,62,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Blazejewska,Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome a 7 Tesla MRI study,2015,Invivo,1,substantia nigra,104,Identification,1,NA,0,3D T2* GRE,3,7.0,1,3,2,62,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,globus pallidus,13,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,caudate,17,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,putamen,19,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,inferior colliculus,47,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,superior colliculus,48,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,mammillary body,53,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,periaqueductal gray,68,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,pons,79,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,red nucleus,91,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,substantia nigra,104,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Bourekas,High Resolution MRI of the Deep Gray Nuclei at 8 Tesla.,1999,Invivo,1,thalamus,115,Identification,1,NA,0,GE 2D T2*,3,8.0,2,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
20,Bouvy ,Visualization of Perivascular Spaces and Perforating Arteries With 7 T Magnetic Resonance Imaging/,2014,Invivo,1,putamen,19,Identification,1,NA,0,T1. T2. T2*. TOF,10,7.0,1,1,0,13,0.5,0.5,0.5,0.125,0.7,0.7,0.7,0.343,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.23,0.3,0.4,0.0276
21,Bouvy ,Perivascular spaces on 7T brain mri are related to markers of small vessel diseas but not to age or cardiovascular risk factors,2016,Invivo,1,basal ganglia,12,Identification,1,NA,0,T2*,3,7.0,1,1,0,50,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,0.3,0.03657,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
22,Budde,Human imaging at 9.4 T using T(2) -. phase-. and susceptibility-weighted contrast.pdf,2011,Invivo,1,globus pallidus,13,Identification,1,NA,0,T2*,3,9.4,3,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
22,Budde,Human imaging at 9.4 T using T(2) -. phase-. and susceptibility-weighted contrast.pdf,2011,Invivo,1,caudate,17,Identification,1,NA,0,T2*,3,9.4,3,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
22,Budde,Human imaging at 9.4 T using T(2) -. phase-. and susceptibility-weighted contrast.pdf,2011,Invivo,1,putamen,19,Identification,1,NA,0,T2*,3,9.4,3,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
22,Budde,Human imaging at 9.4 T using T(2) -. phase-. and susceptibility-weighted contrast.pdf,2011,Invivo,1,claustrum,23,Identification,1,NA,0,T2*,3,9.4,3,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Budde,Ultra-high resolution imaging of the human brain using acquisition-weighted imaging at 9.4T.pdf,2014,Invivo,1,putamen,19,Identification,1,NA,0,Magnitude T2*,3,9.4,3,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.2,0.2,0.5,0.02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,caudate,17,Identification,1,NA,0,MPRAGE,1,7.0,1,1,0,4,0.375,0.375,1.5,0.2109375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,mammillary body,53,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,red nucleus,91,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,substantia nigra,104,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,anterior thalamic nucleus,116,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,anterior thalamic nucleus,116,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,centromedian thalamic nucleus,119,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,medial dorsal thalamic nucleus,121,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,dorsal medial thalamic nucleus. magnocellular part,122,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,dorsal superficial thalamic nucleus,125,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,lateral posterior thalamic nucleus,128,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,pulvinar,136,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,ventral lateral thalamic nucleus,140,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,ventral lateral anterior thalamic nucleus,141,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,ventral lateral posterior thalamic nucleus,142,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,ventral lateral posterior thalamic nucleus,142,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,ventral anterior thalamic nucleus,138,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,Calamante,Super-resolution track-density imaging of thalamic substructures_ comparison with high-resolution anatomical magnetic resonance imaging at 7.0T.pdf,2013,Invivo,1,ventral posterior thalamic nucleus,144,Identification,1,NA,0,DWI,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.8,1.8,1.8,5.832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Chalifoux,The ability of high field strength 7-T magnetic resonance imaging to reveal previously uncharacterized brain lesions in patients with tuberous sclerosis complex.pdf,2013,Invivo,1,striatum,16,Identification,1,NA,0,MPRAGE / T2 weighted,10,7.0,1,2,2,4,NA,NA,NA,NA,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Chalifoux,The ability of high field strength 7-T magnetic resonance imaging to reveal previously uncharacterized brain lesions in patients with tuberous sclerosis complex.pdf,2013,Invivo,1,caudate,17,Identification,1,NA,0,T2 weighted,2,7.0,1,2,2,4,NA,NA,NA,NA,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
26,Chen ,An optimised framework for reconstructing and processing MR phase images..pdf,2010,Invivo,1,caudate,17,Segmentation,2,Manual,1,GE phase T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
26,Chen ,An optimised framework for reconstructing and processing MR phase images..pdf,2010,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,GE phase T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,medula oblongata,11,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,caudate,17,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,crus cerebri,24,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,inferior colliculus,47,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,superior colliculus,48,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,mammillary body,53,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,pons,79,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,red nucleus,91,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,substantia nigra,104,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,thalamus,115,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,centromedian thalamic nucleus,119,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,medial dorsal thalamic nucleus,121,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,ventral lateral thalamic nucleus,140,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27,Cho,New Brain AtlasMapping the Human Brain In Vivo with 7.0 T MRI and Comparison with Postmortem Histology/ Will These Images Change Modern Medicine?,2008,Invivo,1,ventral lateral posterior thalamic nucleus,142,Identification,1,NA,0,2D T2* weighted,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28,Cho,Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging,2010,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,12,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28,Cho,Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging,2010,Invivo,1,globus pallidus external segment,15,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,12,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28,Cho,Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging,2010,Invivo,1,putamen,19,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,12,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28,Cho,Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging,2010,Invivo,1,claustrum,23,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,12,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28,Cho,Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging,2010,Invivo,1,substantia nigra,104,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,12,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28,Cho,Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging,2010,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,12,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Cho,Quantitative analysis of the hippocampus using images obtained from 7.0 T MRI,2010,Invivo,1,amygdala,3,Identification,1,NA,0,3D FLASH,3,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,0.35,0.042875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Cho,Classification of the venous architecture of the pineal gland by 7T MRI,2011,Invivo,1,inferior colliculus,47,Identification,1,NA,0,T2*,3,7.0,1,1,0,34,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Cho,Classification of the venous architecture of the pineal gland by 7T MRI,2011,Invivo,1,superior colliculus,48,Identification,1,NA,0,T2*,3,7.0,1,1,0,34,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Cho,Classification of the venous architecture of the pineal gland by 7T MRI,2011,Invivo,1,mammillary body,53,Identification,1,NA,0,T2*,3,7.0,1,1,0,34,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Cho,Classification of the venous architecture of the pineal gland by 7T MRI,2011,Invivo,1,pineal gland,71,Identification,1,NA,0,T2*,3,7.0,1,1,0,34,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Cho,Classification of the venous architecture of the pineal gland by 7T MRI,2011,Invivo,1,thalamus,115,Identification,1,NA,0,T2*,3,7.0,1,1,0,34,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Cho,Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.pdf,2011,Invivo,1,red nucleus,91,Identification,1,NA,0,2D T2* weighted,3,7.0,1,3,1,19,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Cho,Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.pdf,2011,Invivo,1,substantia nigra,104,Segmentation,2,NA,9999,2D T2* weighted,3,7.0,1,3,1,19,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,anterior thalamic nucleus,116,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,centromedian thalamic nucleus,119,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,medial dorsal thalamic nucleus,121,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,dorsal superficial thalamic nucleus,125,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,pulvinar,136,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,ventral lateral thalamic nucleus,140,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,ventral lateral posterior thalamic nucleus,142,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32,Cho,Observation of glucose metabolism in the thalamic nuclei by fusion PET_MRI.pdf,2011,Invivo,1,ventral anterior thalamic nucleus,138,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,5,0.33,0.33,1.2,0.13068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,globus pallidus,13,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,caudate,17,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,putamen,19,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,superior colliculus,48,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,mammillary body,53,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,pineal gland,71,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,thalamus,115,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,lateral geniculate thalamic nucleus,129,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,medial geniculate thalamic nucleus,133,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33,Christofordidis,High Resolution MRI of the Deep Brain Vascular Anatomy at 8 Tesla Susceptibility-Based Enhancement of the Venous Structures,1999,Invivo,1,pulvinar,136,Identification,1,NA,0,2D GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,parabrachial nucleus,67,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,red nucleus,91,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,retrorubral field,98,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,substantia nigra pars compacta ventralis,106,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,substantia nigra pars compacta dorsalis,107,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,substantia nigra pars reticularis,110,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Cosottini,Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.pdf,2014,Invivo,1,ventral tegmental area,150,Identification,1,NA,0,SWAN,3,7.0,1,3,1,27,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Invivo,1,substantia nigra pars compacta ventralis,106,Identification,1,NA,0,3D SWI,6,7.0,1,3,1,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1,0.097344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Invivo,1,substantia nigra pars compacta dorsalis,107,Identification,1,NA,0,3D SWI,6,7.0,1,3,1,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1,0.097344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Invivo,1,substantia nigra pars reticularis,110,Identification,1,NA,0,3D SWI,6,7.0,1,3,1,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1,0.097344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Exvivo,2,substantia nigra pars compacta ventralis,106,Identification,1,NA,0,SE PD / 2D GRE / 3D SWI,10,7.0,1,1,0,1,NA,NA,NA,NA,0.19,0.19,2.5,0.09025,0.19,0.19,2.5,0.09025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.19,0.19,1,0.361,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Exvivo,2,substantia nigra pars compacta dorsalis,107,Identification,1,NA,0,SE PD / 2D GRE / 3D SWI,10,7.0,1,1,0,1,NA,NA,NA,NA,0.19,0.19,2.5,0.09025,0.19,0.19,2.5,0.09025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.19,0.19,1,0.361,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Exvivo,2,substantia nigra pars reticularis,110,Identification,1,NA,0,SE PD / 2D GRE / 3D SWI,10,7.0,1,1,0,1,NA,NA,NA,NA,0.19,0.19,2.5,0.09025,0.19,0.19,2.5,0.09025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.19,0.19,1,0.361,NA,NA,NA,NA
35,Cosottini ,MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease,2014,Exvivo,2,nigrosome,152,Identification,1,NA,0,SE PD / 2D GRE / 3D SWI,10,7.0,1,1,0,1,NA,NA,NA,NA,0.19,0.19,2.5,0.09025,0.19,0.19,2.5,0.09025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.19,0.19,1,0.361,NA,NA,NA,NA
36,Costagli,Assessment of Silent T1-weighted head imaging at 7 T.,2015,Invivo,1,amygdala,3,Identification,1,NA,0,Silent T1NAweighted,1,7.0,1,1,0,10,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Costagli,Assessment of Silent T1-weighted head imaging at 7 T.,2015,Invivo,1,basal ganglia,12,Identification,1,NA,0,Silent T1NAweighted,1,7.0,1,1,0,10,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,de Hollander,A gradual increase of iron toward the medial-inferior tip of the subthalamic nucleus,2014,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,de Hollander,A gradual increase of iron toward the medial-inferior tip of the subthalamic nucleus,2014,Exvivo,2,subthalamic nucleus,112,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.15,0.15,0.15,0.003375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
38,de Hollander,"Comparing Functional MRI Protocols for Small, Iron-Rich Basal Ganglia Nuclei Such as the Subthalamic Nucleus at 7 T and 3 T",2017,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,De Martino,Spatial organization of frequency preference and selectivity in the human inferior colliculus,2013,Invivo,1,inferior colliculus,47,Segmentation,2,Functional localizer,5,functional EPI,4,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,1.5,3.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,De Martino,Spatial organization of frequency preference and selectivity in the human inferior colliculus,2013,Invivo,1,medial geniculate thalamic nucleus,133,Segmentation,2,Functional localizer,5,functional EPI,4,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,1.5,3.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,globus pallidus,13,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,caudate,17,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,putamen,19,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,claustrum,23,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,dentate nucleus,25,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,mammillary body,53,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,red nucleus,91,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,substantia nigra,104,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,subthalamic nucleus,112,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,thalamus,115,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,de Reuck,Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases_ a semi-quantitative 7.0 T magnetic resonance imaging study.,2014,Exvivo,2,geniculate thalamic body,126,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,152,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
41,de Reuck,Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates.,2014,Exvivo,2,striatum,16,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,25,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
41,de Reuck,Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates.,2014,Exvivo,2,dentate nucleus,25,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,25,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
41,de Reuck,Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates.,2014,Exvivo,2,pons,79,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,25,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
41,de Reuck,Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates.,2014,Exvivo,2,red nucleus,91,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,25,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
41,de Reuck,Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates.,2014,Exvivo,2,substantia nigra,104,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,25,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
41,de Reuck,Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates.,2014,Exvivo,2,thalamus,115,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,25,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,de Reuck,The Significance of Cortical Cerebellar Microbleeds and Microinfarcts in Neurodegenerative and Cerebrovascular Diseases.pdf,2015,Exvivo,2,dentate nucleus,25,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,104,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,de Reuck,Frequency and topography of small cerebrovascular lesions in vascular and in mixed dementia a post-mortem 7-tesla magnetic resonance imaging study with neuropathological correlates.pdf,2017,Exvivo,2,putamen,19,Identification,1,NA,0,GRE T2*,3,7.0,1,3,8,49,NA,NA,NA,NA,NA,NA,NA,NA,0.176,0.176,0.2,0.0061952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Deistung,High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla,2013,Invivo,1,inferior colliculus,47,Segmentation,2,Manual VOI within visual identified region,2,Mainly on the R1,1,7.0,1,1,0,6,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Deistung,High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla,2013,Invivo,1,superior colliculus,48,Segmentation,2,Manual VOI within visual identified region,2,Mainly on the R1,1,7.0,1,1,0,6,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Deistung,High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla,2013,Invivo,1,mammillary body,53,Identification,1,NA,0,All but the DWI,10,7.0,1,1,0,6,0.6,0.6,0.6,0.216,0.53,0.53,0.9,0.25281,0.43,0.43,0.43,0.079507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Deistung,High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla,2013,Invivo,1,red nucleus,91,Segmentation,2,Manual VOI within visual identified region,2,All but the R1,10,7.0,1,1,0,6,NA,NA,NA,NA,0.53,0.53,0.9,0.25281,0.43,0.43,0.43,0.079507,NA,NA,NA,NA,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Deistung,High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla,2013,Invivo,1,spinal nucleus of the trigeminal nerve,101,Identification,1,NA,0,QSM,6,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,0.43,0.43,0.43,0.079507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Deistung,High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla,2013,Invivo,1,substantia nigra,104,Segmentation,2,Manual VOI within visual identified region,2,All but the R1,10,7.0,1,1,0,6,NA,NA,NA,NA,0.53,0.53,0.9,0.25281,0.43,0.43,0.43,0.079507,NA,NA,NA,NA,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,globus pallidus internal segment,14,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,globus pallidus external segment,15,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,globus pallidus external segment,15,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,head of the caudate nucleus,18,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,putamen,19,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,superior colliculus,48,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,mammillary body,53,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,red nucleus pars caudalis,93,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,red nucleus pars oralis,95,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,red nucleus pars dorsomedialis,96,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,substantia nigra pars compacta,105,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,substantia nigra pars reticularis,110,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,thalamus,115,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,antereoprinciple thalamic nucleus,118,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,dorsal thalamus,120,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,medial dorsal thalamic nucleus,121,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,lateral geniculate thalamic nucleus,129,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,medial geniculate thalamic nucleus,133,Identification,1,NA,0,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
45,Deistung,Toward in vivo histology a comparison of quantitative susceptibility mapping (QSM) with magnitude-. phase-. and R2-imaging at ultra-high magnetic field strength.,2013,Invivo,1,pulvinar,136,Segmentation,2,Manual,1,Susceptibility maps,6,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Denison,Functional mapping of the magnocellular and parvocellular subdivisions of human LGN.,2014,Invivo,1,lateral geniculate thalamic nucleus magnocellular part,130,Segmentation,2,functional localizer,5,T2* EPI,4,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.25,1.25,1.2,1.875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Denison,Functional mapping of the magnocellular and parvocellular subdivisions of human LGN.,2014,Invivo,1,lateral geniculate thalamic nucleus parvocelluar,131,Segmentation,2,functional localizer,5,T2* EPI,4,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.25,1.25,1.2,1.875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Derix,Visualization of the amygdalo-hippocampal border and its structural variability by 7T and 3T magnetic resonance imaging.,2014,Invivo,1,amygdala,3,Identification,1,NA,0,T1 MPRAGE,1,7.0,1,1,0,6,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Dezortova,Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients.,2012,Invivo,1,globus pallidus,13,Segmentation,2,Manual VOI within visual identified region,2,T2 maps,2,7.0,1,3,8,11,NA,NA,NA,NA,9999,9999,0.5,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Dezortova,Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients.,2012,Invivo,1,caudate,17,Segmentation,2,Manual VOI within visual identified region,2,T2 maps,2,7.0,1,3,8,11,NA,NA,NA,NA,9999,9999,0.5,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Dezortova,Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients.,2012,Invivo,1,putamen,19,Segmentation,2,Manual VOI within visual identified region,2,T2 maps,2,7.0,1,3,8,11,NA,NA,NA,NA,9999,9999,0.5,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Di Leva,The veins of the nucleus dentatus anatomical and radiological findings.,2011,Invivo,1,dentate nucleus,25,Identification,1,NA,0,SWI,6,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,1.2,0.108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Diedrichsen,Imaging the deep cerebellar nuclei a probabilistic atlas and normalization procedure.,2011,Invivo,1,interposed nucleus,20,Segmentation,2,Manual,1,highNApass filtered phase images,6,7.0,1,1,0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Diedrichsen,Imaging the deep cerebellar nuclei a probabilistic atlas and normalization procedure.,2011,Invivo,1,fastigial nucleus,21,Segmentation,2,Manual,1,highNApass filtered phase images,6,7.0,1,1,0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Diedrichsen,Imaging the deep cerebellar nuclei a probabilistic atlas and normalization procedure.,2011,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,highNApass filtered phase images,6,7.0,1,1,0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Dortch,Quantitative magnetization transfer imaging of human brain at 7 T.,2013,Invivo,1,head of the caudate nucleus,18,Identification,1,NA,0,qMT,7,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,3,12,NA,NA,NA,NA,NA,NA,NA,NA
51,Dortch,Quantitative magnetization transfer imaging of human brain at 7 T.,2013,Invivo,1,putamen,19,Identification,1,NA,0,qMT,7,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,3,12,NA,NA,NA,NA,NA,NA,NA,NA
51,Dortch,Quantitative magnetization transfer imaging of human brain at 7 T.,2013,Invivo,1,thalamus,115,Identification,1,NA,0,qMT,7,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,3,12,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,mammillary body,53,Identification,1,NA,0,both T2 and T2*,10,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,red nucleus,91,Segmentation,2,Automatic,4,2D T2 GRASE,2,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,red nucleus. densely vascularized part,92,Identification,1,NA,0,both T2 and T2*,10,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,red nucleus. poorly vascularized part,97,Identification,1,NA,0,both T2 and T2*,10,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,substantia nigra,104,Segmentation,2,Automatic,4,2D T2 GRASE,2,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,substantia nigra pars compacta,105,Identification,1,NA,0,both T2 and T2*,10,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,substantia nigra pars reticularis,110,Identification,1,NA,0,both T2 and T2*,10,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Eapen,Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.,2011,Invivo,1,ventral tegmental area,150,Segmentation,2,Automatic,4,2D T2 GRASE,2,7.0,1,1,0,10,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Emir,Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS.,2012,Invivo,1,putamen,19,Identification,1,NA,0,MPRAGE,1,7.0,1,3,1,25,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Emir,Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS.,2012,Invivo,1,pons,79,Identification,1,NA,0,MPRAGE,1,7.0,1,3,1,25,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Emir,Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS.,2012,Invivo,1,substantia nigra,104,Identification,1,NA,0,TSE,2,7.0,1,3,1,25,NA,NA,NA,NA,9999,9999,3.0,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,amygdala,3,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,globus pallidus,13,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,caudate,17,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,putamen,19,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,periaquaductal gray. lateral column,69,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,periaquaductal gray. caudal dorsolateral column,70,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,red nucleus,91,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,medial dorsal thalamic nucleus,121,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,ventral lateral posterior thalamic nucleus,142,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,Faull,Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI.,2015,Invivo,1,ventral medial posterior thalamic nucleus,145,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,caudate,17,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,putamen,19,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,globus pallidus external segment,15,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,red nucleus,91,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,mammillary body,53,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,pulvinar,136,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,ventral lateral posterior thalamic nucleus,142,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,claustrum,23,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,periaqueductal gray,68,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,superior colliculus,48,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,inferior colliculus,47,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,ventral anterior thalamic nucleus,138,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,ventral lateral thalamic nucleus,140,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,medial dorsal thalamic nucleus,121,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,medial geniculate thalamic nucleus,129,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,lateral geniculate thalamic nucleus,133,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,Area triangularis of wernicke,159,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,ventral medial thalamic nucleus,163,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,"ventral lateral posterior thalamic nucleus, dorsal devision",160,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,"ventral lateral posterior thalamic nucleus, ventral devision",161,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,substantia nigra pars compacta,105,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,substantia nigra pars reticularis,110,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,amygdala,3,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
55,Federau,Motion correction enabled ultra high resolution in vivo 7T mri of the brain,2016,Invivo,1,tail of caudate,162,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,1,0.35,0.35,0.35,0.0429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Foroutan,High-Field-Strength MR Microscopy in the Human Substantia Nigra and Globus Pallidus,2013,Exvivo,2,globus pallidus internal segment,14,Segmentation,2,Manual,1,T2* ,3,21.1,4,3,8,9,NA,NA,NA,NA,NA,NA,NA,NA,0.05,0.05,0.05,0.000125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Foroutan,High-Field-Strength MR Microscopy in the Human Substantia Nigra and Globus Pallidus,2013,Exvivo,2,globus pallidus external segment,15,Segmentation,2,Manual,1,T2* ,3,21.1,4,3,8,9,NA,NA,NA,NA,NA,NA,NA,NA,0.05,0.05,0.05,0.000125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Foroutan,High-Field-Strength MR Microscopy in the Human Substantia Nigra and Globus Pallidus,2013,Exvivo,2,putamen,19,Segmentation,2,Manual,1,T2* ,3,21.1,4,3,8,9,NA,NA,NA,NA,NA,NA,NA,NA,0.05,0.05,0.05,0.000125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Foroutan,High-Field-Strength MR Microscopy in the Human Substantia Nigra and Globus Pallidus,2013,Exvivo,2,red nucleus,91,Segmentation,2,Manual,1,T2* ,3,21.1,4,3,8,9,NA,NA,NA,NA,NA,NA,NA,NA,0.05,0.05,0.05,0.000125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Foroutan,High-Field-Strength MR Microscopy in the Human Substantia Nigra and Globus Pallidus,2013,Exvivo,2,substantia nigra,104,Segmentation,2,Manual,1,T2* ,3,21.1,4,3,8,9,NA,NA,NA,NA,NA,NA,NA,NA,0.05,0.05,0.05,0.000125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Forstmann,Cortico-Striatal Connections Predict Control over Speed and Accuracy in Perceptual Decision Making.pdf,2010,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
58,Forstmann,Cortico-subthalamic white matter tract strength predicts interindividual efficacy in stopping a motor response.,2012,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,T2* ,3,7.0,1,1,0,54,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,globus pallidus external segment,15,Identification,1,NA,0,T2* ,3,7.0,1,1,0,54,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,caudate,17,Identification,1,NA,0,T1,1,7.0,1,1,0,54,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,putamen,19,Identification,1,NA,0,T1,1,7.0,1,1,0,54,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,claustrum,23,Identification,1,NA,0,T1,1,7.0,1,1,0,54,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,habenula,35,Identification,1,NA,0,T1,1,7.0,1,1,0,54,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,pineal gland,71,Identification,1,NA,0,T1,1,7.0,1,1,0,54,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,red nucleus,91,Identification,1,NA,0,T2* ,3,7.0,1,1,0,54,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,substantia nigra,104,Identification,1,NA,0,T2* ,3,7.0,1,1,0,54,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,T2* ,3,7.0,1,1,0,54,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59,Forstmann,Multi-modal ultra-high resolution structural 7-Tesla MRI data repository.,2014,Invivo,1,thalamus,115,Identification,1,NA,0,T1,1,7.0,1,1,0,54,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Forstmann,UFH MRI guided DBS,2017,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,T2* ,3,7.0,1,2,1,1,NA,NA,NA,NA,NA,NA,NA,NA,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Forstmann,UFH MRI guided DBS,2017,Invivo,1,globus pallidus,13,Identification,1,NA,0,T2* ,3,7.0,1,2,1,1,NA,NA,NA,NA,NA,NA,NA,NA,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Forstmann,UFH MRI guided DBS,2017,Invivo,1,anterior thalamic nucleus,116,Identification,1,NA,0,T1,1,7.0,1,2,1,1,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Forstmann,UFH MRI guided DBS,2017,Invivo,1,accumbens area,2,Identification,1,NA,0,T1,1,7.0,1,2,1,1,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Fritzsch,Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation.,2014,Invivo,1,globus pallidus,13,Segmentation,2,Manual,1,QSM,6,7.0,1,3,4,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.8,0.288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Fritzsch,Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation.,2014,Invivo,1,head of the caudate nucleus,18,Segmentation,2,Manual,1,QSM,6,7.0,1,3,4,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.8,0.288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Fritzsch,Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation.,2014,Invivo,1,putamen,19,Segmentation,2,Manual,1,QSM,6,7.0,1,3,4,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.8,0.288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Fritzsch,Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation.,2014,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,QSM,6,7.0,1,3,4,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.8,0.288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Fritzsch,Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation.,2014,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,QSM,6,7.0,1,3,4,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.8,0.288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Frosini ,Nigral involvement in atypical parkinsonisms- evidence from a pilot study with uhf mri,2016,Invivo,1,nigrosome,152,Identification,1,NA,0,SWI,6,7.0,1,3,1,25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.312,0.312,1.2,0.1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
63,Fujioka,Magnetic resonance imaging with 21.1 T and pathological correlations diffuse Lewy body disease.,2011,Exvivo,2,globus pallidus internal segment,14,Identification,1,NA,0,T2 and T2*,10,21.1,4,3,8,2,NA,NA,NA,NA,0.1,0.1,0.55,0.0055,0.1,0.1,0.55,0.0055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
63,Fujioka,Magnetic resonance imaging with 21.1 T and pathological correlations diffuse Lewy body disease.,2011,Exvivo,2,globus pallidus external segment,15,Identification,1,NA,0,T2 and T2*,10,21.1,4,3,8,2,NA,NA,NA,NA,0.1,0.1,0.55,0.0055,0.1,0.1,0.55,0.0055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
63,Fujioka,Magnetic resonance imaging with 21.1 T and pathological correlations diffuse Lewy body disease.,2011,Exvivo,2,putamen,19,Identification,1,NA,0,T2 and T2*,10,21.1,4,3,8,2,NA,NA,NA,NA,0.1,0.1,0.55,0.0055,0.1,0.1,0.55,0.0055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
64,Ghaznawi,Detection and characterization of small infarcts in the caudate nucleus on 7T mri - the SMRT MR study,2017,Invivo,1,caudate,17,Identification,1,NA,0,T1 and T2 and FLAIR,10,7.0,1,2,8,90,0.66,0.66,0.5,0.2178,0.35,0.35,0.35,0.04288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
65,Gizewski,fMRI at 7 T whole-brain coverage and signal advantages even infratentorially.,2007,Invivo,1,thalamus,115,Identification,1,NA,0,functional EPI,4,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.44,3.44,3.3,39.05088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
66,Gizewski,High-resolution anatomy of the human brain stem using 7-T MRI improved detection of inner structures and nerves.,2013,Invivo,1,nucleus nerve abducens,61,Identification,1,NA,0,PD,8,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,2,0.5,NA,NA,NA,NA
66,Gizewski,High-resolution anatomy of the human brain stem using 7-T MRI improved detection of inner structures and nerves.,2013,Invivo,1,nucleus nerve trigemini,62,Identification,1,NA,0,3D T2 and SWI,10,7.0,1,1,0,8,NA,NA,NA,NA,0.5,0.5,1,0.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,1,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
66,Gizewski,High-resolution anatomy of the human brain stem using 7-T MRI improved detection of inner structures and nerves.,2013,Invivo,1,olivary complex,66,Identification,1,NA,0,3D T2 ,2,7.0,1,1,0,8,NA,NA,NA,NA,0.5,0.5,1,0.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
66,Gizewski,High-resolution anatomy of the human brain stem using 7-T MRI improved detection of inner structures and nerves.,2013,Invivo,1,periaqueductal gray,68,Identification,1,NA,0,PD. 3D T.2 and SWI,10,7.0,1,1,0,8,NA,NA,NA,NA,0.5,0.5,1,0.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,1,0.0625,NA,NA,NA,NA,0.5,0.5,2,0.5,NA,NA,NA,NA
66,Gizewski,High-resolution anatomy of the human brain stem using 7-T MRI improved detection of inner structures and nerves.,2013,Invivo,1,raphe nuclei,84,Identification,1,NA,0,PD,8,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,2,0.5,NA,NA,NA,NA
66,Gizewski,High-resolution anatomy of the human brain stem using 7-T MRI improved detection of inner structures and nerves.,2013,Invivo,1,vestibular nuclei,149,Identification,1,NA,0,PD,8,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,2,0.5,NA,NA,NA,NA
67,Gorka,Intrinsic funcitonal connectivity of the central nucleus of the amygdala and bed nucleus of the stria terminalis,2017,Invivo,1,bed nucleus of the stria terminalis,153,Segmentation,2,Manual,1,T1,1,7.0,1,1,0,27,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
68,Graber,A study-specific fMRI normalization approach that operates directly on high resolution functional EPI data at 7 Tesla.,2014,Invivo,1,dentate nucleus,25,Segmentation,2,functional localizer,5,functional EPI,4,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,1.1,1.331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,globus pallidus external segment,15,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,caudate,17,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,putamen,19,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,periaqueductal gray,68,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,pons,79,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,red nucleus,91,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,substantia nigra,104,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69,Hammond,Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases,2008,Invivo,1,thalamus,115,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,3,8,47,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,2,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Hammond,Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.,2008,Invivo ,1,globus pallidus,13,Segmentation,2,Manual (slice),2,Magnitude and Phase GRE,3,7.0,1,3,2,32,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.26,2,0.1014,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Hammond,Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.,2008,Invivo ,1,caudate,17,Segmentation,2,Manual (slice),2,Magnitude and Phase GRE,3,7.0,1,3,2,32,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.26,2,0.1014,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Hammond,Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.,2008,Invivo ,1,putamen,19,Segmentation,2,Manual (slice),2,Magnitude and Phase GRE,3,7.0,1,3,2,32,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.26,2,0.1014,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Hammond,Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.,2008,Invivo ,1,thalamus,115,Segmentation,2,Manual (slice),2,Magnitude and Phase GRE,3,7.0,1,3,2,32,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.26,2,0.1014,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,medial anterior thalamic nucleus,117,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,centromedian thalamic nucleus,119,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,nucleus dorso-oralis internus thalamus,123,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,nucleus dorso-oralis externus thalamus,124,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,lateral posterior thalamic nucleus,128,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,reticulatum thalamus,137,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
71,Kanowski,Direct visualization of anatomic subfields within the superior aspect of the human lateral thalamus by MRI at 7T.pdf,2014,Invivo,1,nucleus zentrolateralis intermedius internus thalamus,146,Identification,1,NA,0,IRNATSE,2,7.0,1,1,0,5,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Keren,Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.,2015,Exvivo,2,locus coeruleus,52,Identification,1,NA,0,T1NAweighted TSE,1,7.0,1,2,8,7,0.078,0.078,2.5,0.01521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Keren,Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.,2015,Exvivo,2,periaqueductal gray,68,Identification,1,NA,0,T1NAweighted TSE,1,7.0,1,2,8,7,0.078,0.078,2.5,0.01521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Keren,Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.,2015,Exvivo,2,inferior colliculus,47,Identification,1,NA,0,T1NAweighted TSE,1,7.0,1,2,8,7,0.078,0.078,2.5,0.01521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kerl,The subthalamic nucleus at 7.0 Tesla evaluation of sequence and orientation for deep-brain stimulation.,2012,Invivo,1,red nucleus,91,Identification,1,NA,0,2D T2* coronal & SWI,10,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.52,0.52,0.5,0.1352,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kerl,The subthalamic nucleus at 7.0 Tesla evaluation of sequence and orientation for deep-brain stimulation.,2012,Invivo,1,substantia nigra,104,Identification,1,NA,0,2D T2* coronal & SWI,10,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.52,0.52,0.5,0.1352,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kerl,The subthalamic nucleus at 7.0 Tesla evaluation of sequence and orientation for deep-brain stimulation.,2012,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual VOI within visual identified region,2,2D T2* coronal & SWI,10,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.52,0.52,0.5,0.1352,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kerl,The subthalamic nucleus at 7.0 Tesla evaluation of sequence and orientation for deep-brain stimulation.,2012,Invivo,1,zona incerta,151,Identification,1,NA,0,2D T2* coronal & SWI,10,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.52,0.52,0.5,0.1352,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
74,Kerl,Imaging for deep brain stimulation The zona incerta at 7 Tesla.,2013,Invivo,1,globus pallidus,13,Identification,1,NA,0,2D T2*,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
74,Kerl,Imaging for deep brain stimulation The zona incerta at 7 Tesla.,2013,Invivo,1,red nucleus,91,Identification,1,NA,0,2D T2*,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
74,Kerl,Imaging for deep brain stimulation The zona incerta at 7 Tesla.,2013,Invivo,1,substantia nigra,104,Identification,1,NA,0,2D T2*,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
74,Kerl,Imaging for deep brain stimulation The zona incerta at 7 Tesla.,2013,Invivo,1,zona incerta,151,Identification,1,NA,0,2D T2*,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
74,Kerl,Imaging for deep brain stimulation The zona incerta at 7 Tesla.,2013,Invivo,1,zona incerta,151,Segmentation,2,Manual VOI within visual identified region,2,2D T2* coronal,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Keuken,Ultra-high 7T MRI of structural age-related changes of the subthalamic nucleus.,2013,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,31,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Keuken,The subthalamic nucleus during decision-making with multiple alternatives.,2015,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,15,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Keuken ,Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI.,2014,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,30,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Keuken ,Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI.,2014,Invivo,1,globus pallidus internal segment,14,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Keuken ,Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI.,2014,Invivo,1,globus pallidus external segment,15,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Keuken ,Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI.,2014,Invivo,1,striatum,16,Segmentation,2,Manual,1,T1,1,7.0,1,1,0,30,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Keuken ,Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI.,2014,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,30,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Keuken ,Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI.,2014,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,30,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,53,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,globus pallidus internal segment,14,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,53,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,globus pallidus external segment,15,Segmentation,2,Manual,1,QSM,6,7.0,1,1,0,53,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,striatum,16,Segmentation,2,Manual,1,T1,1,7.0,1,1,0,53,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,53,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,3D T2*,3,7.0,1,1,0,53,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Keuken,"Effects of aging on T1, T2* and QSM values in the subcortex",2017,Invivo,1,periaqueductal gray,68,Segmentation,2,Manual,1,T1,1,7.0,1,1,0,53,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Khabipova,A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge.,2015,Invivo,1,globus pallidus,13,Segmentation,2,Manual,1,T2* GRE multi echo,3,7.0,1,3,2,4,NA,NA,NA,NA,NA,NA,NA,NA,0.66,0.66,0.66,0.287496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Khabipova,A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge.,2015,Invivo,1,caudate,17,Segmentation,2,Manual,1,T2* GRE multi echo,3,7.0,1,3,2,4,NA,NA,NA,NA,NA,NA,NA,NA,0.66,0.66,0.66,0.287496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Khabipova,A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge.,2015,Invivo,1,putamen,19,Segmentation,2,Manual,1,T2* GRE multi echo,3,7.0,1,3,2,4,NA,NA,NA,NA,NA,NA,NA,NA,0.66,0.66,0.66,0.287496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Khabipova,A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge.,2015,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,T2* GRE multi echo,3,7.0,1,3,2,4,NA,NA,NA,NA,NA,NA,NA,NA,0.66,0.66,0.66,0.287496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Khabipova,A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge.,2015,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,T2* GRE multi echo,3,7.0,1,3,2,4,NA,NA,NA,NA,NA,NA,NA,NA,0.66,0.66,0.66,0.287496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Kim,Identification and morphologic assessment of mesocoelic recess by in vivo human brain imaging with 7.0-T magnetic resonance imaging.,2011,Invivo,1,mesocoelic recess,56,Segmentation,2,Manual,1,2D T2NAweighted,2,7.0,1,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Kim,Identification and morphologic assessment of mesocoelic recess by in vivo human brain imaging with 7.0-T magnetic resonance imaging.,2011,Invivo,1,tectal plate,114,Identification,1,NA,0,2D T2NAweighted,2,7.0,1,1,0,20,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,2,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,globus pallidus internal segment,14,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,globus pallidus external segment,15,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,caudate,17,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,putamen,19,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Kim,Semiautomatic segmentation of brain subcortical structures from high-field MRI.,2014,Invivo,1,thalamus,115,Segmentation,2,Manual,1,n.s.,9999,7.0,1,9999,9999,5,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,medula oblongata,11,Identification,1,NA,0,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,inferior colliculus,47,Identification,1,NA,0,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,superior colliculus,48,Identification,1,NA,0,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,pons,79,Identification,1,NA,0,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,dorsal raphe R1,86,Segmentation,2,Manual,1,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,median raphe R2,87,Segmentation,2,Manual,1,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,pontis raphe R3,88,Segmentation,2,Manual,1,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,caudal Raphe R4,89,Segmentation,2,Manual,1,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,caudal Raphe R5,90,Segmentation,2,Manual,1,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
82,Kim,Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei An ultra-high resolution PET MRI study.,2015,Invivo,1,thalamus,115,Identification,1,NA,0,PET overlaid on T1,9,7.0,1,1,0,16,0.18,0.18,1.5,0.0486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Kim,Serotonin transporter availability in thalamic subregions in schizophrenia_ A study using 7.0-T MRI with [11C]DASB high-resolution PET.,2015,Invivo,1,anterior thalamic nucleus,116,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,3,8,27,0.7,0.7,1.5,0.735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Kim,Serotonin transporter availability in thalamic subregions in schizophrenia_ A study using 7.0-T MRI with [11C]DASB high-resolution PET.,2015,Invivo,1,medial dorsal thalamic nucleus,121,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,3,8,27,0.7,0.7,1.5,0.735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Kim,Serotonin transporter availability in thalamic subregions in schizophrenia_ A study using 7.0-T MRI with [11C]DASB high-resolution PET.,2015,Invivo,1,pulvinar,136,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,3,8,27,0.7,0.7,1.5,0.735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
84,Kim,"Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinsons disease, multiple system atrophy and progressive supranuclear palsy",2016,Invivo,1,substantia nigra,104,Identification,1,NA,0,T2* GRE,3,7.0,1,3,8,66,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,1,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
85,Kim,Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia - a high resolution ped study ussin 11cDASB and 18fFDG,2017,Invivo,1,median raphe R2,88,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,3,8,37,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
85,Kim,Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia - a high resolution ped study ussin 11cDASB and 18fFDG,2017,Invivo,1,caudal Raphe R4,89,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,3,8,37,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
86,Kim,Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas- an ultra-hihg resolution pet/mri fusion study using 18fFDG,2018,Invivo,1,caudate,17,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,9999,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
86,Kim,Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas- an ultra-hihg resolution pet/mri fusion study using 18fFDG,2018,Invivo,1,putamen,19,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,9999,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
86,Kim,Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas- an ultra-hihg resolution pet/mri fusion study using 18fFDG,2018,Invivo,1,accumbens area,2,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,9999,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
86,Kim,Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas- an ultra-hihg resolution pet/mri fusion study using 18fFDG,2018,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,9999,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
86,Kim,Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas- an ultra-hihg resolution pet/mri fusion study using 18fFDG,2018,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,9999,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
87,Kirov,In vivo 7 Tesla imaging of the dentate granule cell layer in schizophrenia.,2013,Invivo,1,red nucleus,91,Identification,1,NA,0,T2*NAweighted,3,7.0,1,3,8,31,NA,NA,NA,NA,NA,NA,NA,NA,0.232,0.232,1.5,0.080736,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
88,Kollia,First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis comparison of 1.5T and 7T.,2009,Invivo,1,dentate nucleus,25,Identification,1,NA,0,T2*NAweighted,3,7.0,1,2,2,12,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,2,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
89,Kuper,Evidence for a motor and a non-motor domain in the human dentate nucleus--an fMRI study.,2011,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,mean functional EPI,4,7.0,1,1,0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,1.9,7.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
90,Kuper,Evidence for a motor somatotopy in the cerebellar dentate nucleus-an FMRI study in humans.,2012,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,mean functional EPI,4,7.0,1,1,0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,1.9,7.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
91,Kuper,Activation of the cerebellar cortex and the dentate nucleus in a prism adaptation fMRI study.,2015,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,mean functional EPI,4,7.0,1,1,0,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,1.9,7.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
92,Kwon,Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.,2012,Invivo,1,red nucleus,91,Identification,1,NA,0,3D T2*NAweighted,3,7.0,1,3,1,20,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,0.35,0.042875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
92,Kwon,Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.,2012,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,3D T2*NAweighted,3,7.0,1,3,1,20,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,0.35,0.042875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
92,Kwon,Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.,2012,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,3D T2*NAweighted,3,7.0,1,3,1,20,NA,NA,NA,NA,NA,NA,NA,NA,0.35,0.35,0.35,0.042875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
93,Lee,An investigation of lateral geniculate nucleus volume in patients with primary open-angle glaucoma using 7 tesla magnetic resonance imaging.,2014,Invivo,1,lateral geniculate thalamic nucleus,129,Segmentation,2,Manual,1,PDNAweighted,8,7.0,1,3,8,36,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9999,9999,0.6,9999,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,globus pallidus internal segment,14,Segmentation,2,Manual,1,SWI combined with T2,10,7.0,1,1,0,4,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,1,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,globus pallidus external segment,15,Segmentation,2,Manual,1,SWI combined with T2,10,7.0,1,1,0,4,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,1,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,caudate,17,Segmentation,2,Manual,1,FA ,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,1.5,3.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,putamen,19,Segmentation,2,Manual,1,FA ,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,1.5,3.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,SWI combined with T2,10,7.0,1,1,0,4,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,1,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,SWI combined with T2,10,7.0,1,1,0,4,NA,NA,NA,NA,0.4,0.4,2,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,1,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94,Lenglet,Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI.,2012,Invivo,1,thalamus,115,Segmentation,2,Manual,1,FA ,5,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,1.5,3.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Invivo,1,globus pallidus,13,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,43,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.5,0.18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Exvivo,2,globus pallidus,13,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,3,NA,NA,NA,NA,NA,NA,NA,NA,0.18,0.18,0.18,0.005832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Invivo,1,head of the caudate nucleus,18,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,43,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.5,0.18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Exvivo,2,head of the caudate nucleus,18,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,3,NA,NA,NA,NA,NA,NA,NA,NA,0.18,0.18,0.18,0.005832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Invivo,1,putamen,19,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,43,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.5,0.18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Exvivo,2,putamen,19,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,3,NA,NA,NA,NA,NA,NA,NA,NA,0.18,0.18,0.18,0.005832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Invivo,1,thalamus,115,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,43,NA,NA,NA,NA,NA,NA,NA,NA,0.6,0.6,0.5,0.18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95,Liem,7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.,2012,Exvivo,2,thalamus,115,Segmentation,2,Manual (slice),2,T2*NAweighted,3,7.0,1,3,8,3,NA,NA,NA,NA,NA,NA,NA,NA,0.18,0.18,0.18,0.005832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
96,Liu,Development of the human fetal cerebellum in the second trimester a post mortem magnetic resonance imaging evaluation.,2011,Exvivo,2,dentate nucleus,25,Identification,1,NA,0,T2NAweighted,2,7.0,1,2,7,40,NA,NA,NA,NA,0.23,0.23,0.5,0.02645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
97,Lotfipour,High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.,2012,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,SWI,6,7.0,1,3,2,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.5,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
97,Lotfipour,High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.,2012,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,SWI,6,7.0,1,3,2,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.5,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
97,Lotfipour,High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.,2012,Invivo,1,substantia nigra pars compacta,105,Segmentation,2,Manual,1,SWI,6,7.0,1,3,2,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.5,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
98,Makris,Volumetric parcellation methodology of the human hypothalamus in neuroimaging Normative data and sex differences.,2013,Exvivo,2,anterior-inferior hypothalamus,42,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.09,0.09,0.09,0.000729,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
98,Makris,Volumetric parcellation methodology of the human hypothalamus in neuroimaging Normative data and sex differences.,2013,Exvivo,2,anterior-superior hypothalamus,43,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.09,0.09,0.09,0.000729,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
98,Makris,Volumetric parcellation methodology of the human hypothalamus in neuroimaging Normative data and sex differences.,2013,Exvivo,2,inferior tuberal hypothalamus,44,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.09,0.09,0.09,0.000729,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
98,Makris,Volumetric parcellation methodology of the human hypothalamus in neuroimaging Normative data and sex differences.,2013,Exvivo,2,posterior hypothalamus,45,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.09,0.09,0.09,0.000729,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
98,Makris,Volumetric parcellation methodology of the human hypothalamus in neuroimaging Normative data and sex differences.,2013,Exvivo,2,superior tuberal hypothalamus,46,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.09,0.09,0.09,0.000729,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
99,Marques,Cerebellar cortical layers in vivo visualization with structural high-field-strength MR imaging.,2010,Invivo,1,dentate nucleus,25,Identification,1,NA,0,Magnitude and Phase GRE,3,7.0,1,1,0,3,NA,NA,NA,NA,NA,NA,NA,NA,0.12,0.12,1,0.0144,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
100,Marques,New Developments and Applications of the MP2RAGE Sequence - Focusing the Contrast and High Spatial Resolution R1 Mapping.pdf,2013,Invivo,1,brain stem,10,Segmentation,2,Manual,1,MP2RAGEwmgm,1,7.0,1,1,0,7,0.85,0.85,0.85,0.614125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
100,Marques,New Developments and Applications of the MP2RAGE Sequence - Focusing the Contrast and High Spatial Resolution R1 Mapping.pdf,2013,Invivo,1,caudate,17,Segmentation,2,Manual,1,MP2RAGEwmgm,1,7.0,1,1,0,7,0.85,0.85,0.85,0.614125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
100,Marques,New Developments and Applications of the MP2RAGE Sequence - Focusing the Contrast and High Spatial Resolution R1 Mapping.pdf,2013,Invivo,1,putamen,19,Segmentation,2,Manual,1,MP2RAGEwmgm,1,7.0,1,1,0,7,0.85,0.85,0.85,0.614125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
100,Marques,New Developments and Applications of the MP2RAGE Sequence - Focusing the Contrast and High Spatial Resolution R1 Mapping.pdf,2013,Invivo,1,medial thalamus,132,Segmentation,2,Manual,1,MP2RAGEwmgm,1,7.0,1,1,0,7,0.85,0.85,0.85,0.614125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
100,Marques,New Developments and Applications of the MP2RAGE Sequence - Focusing the Contrast and High Spatial Resolution R1 Mapping.pdf,2013,Invivo,1,outer thalamus,135,Segmentation,2,Manual,1,MP2RAGEwmgm,1,7.0,1,1,0,7,0.85,0.85,0.85,0.614125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,globus pallidus,13,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,globus pallidus internal segment,14,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,h field of forel,32,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,h1 field of forel,33,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,h2 field of forel,34,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,habenula,35,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,hypothalamus,41,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,superior colliculus,48,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,mammillary body,53,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,red nucleus,91,Segmentation,2,Manual,1,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,substantia nigra,104,Segmentation,2,Manual,1,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,subthalamic nucleus,112,Segmentation,2,Manual,1,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,thalamus,115,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,centromedian thalamic nucleus,119,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,lateral geniculate thalamic nucleus,129,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,medial geniculate thalamic nucleus,133,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,pulvinar,136,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
101,Massey,High resolution MR anatomy of the subthalamic nucleus imaging at 9.4 T with histological validation.,2012,Exvivo,2,zona incerta,151,Identification,1,NA,0,T2NAweighted,2,9.4,3,1,0,8,NA,NA,NA,NA,0.044,0.044,0.5,0.000968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102,Meijer,Nigrosome-1 on SWI to differentiate parkinson's disease from atypical parkinsonism- an in vivo and ex vivo pilot study,2016,Exvivo,2,nigrosome,152,Identification,1,NA,0,T2*,3,11.7,4,3,1,4,NA,NA,NA,NA,NA,NA,NA,NA,0.122,0.122,0.122,0.0018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102,Meijer,Nigrosome-1 on SWI to differentiate parkinson's disease from atypical parkinsonism- an in vivo and ex vivo pilot study,2016,Exvivo,2,substantia nigra pars compacta,105,Identification,1,NA,0,T2*,3,11.7,4,3,1,4,NA,NA,NA,NA,NA,NA,NA,NA,0.122,0.122,0.122,0.0018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102,Meijer,Nigrosome-1 on SWI to differentiate parkinson's disease from atypical parkinsonism- an in vivo and ex vivo pilot study,2016,Exvivo,2,red nucleus,91,Identification,1,NA,0,T2*,3,11.7,4,3,1,4,NA,NA,NA,NA,NA,NA,NA,NA,0.122,0.122,0.122,0.0018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
103,Meng,Development of the subcortical brain structures in the second trimester assessment with 7.0-T MRI.,2012,Exvivo,2,caudate,17,Segmentation,2,Manual,1,T2NAweighted,2,7.0,1,2,7,69,NA,NA,NA,NA,0.23,0.23,0.5,0.02645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
103,Meng,Development of the subcortical brain structures in the second trimester assessment with 7.0-T MRI.,2012,Exvivo,2,claustrum,23,Segmentation,2,Manual,1,T2NAweighted,2,7.0,1,2,7,69,NA,NA,NA,NA,0.23,0.23,0.5,0.02645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
103,Meng,Development of the subcortical brain structures in the second trimester assessment with 7.0-T MRI.,2012,Exvivo,2,germinal matrix,31,Segmentation,2,Manual,1,T2NAweighted,2,7.0,1,2,7,69,NA,NA,NA,NA,0.23,0.23,0.5,0.02645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
103,Meng,Development of the subcortical brain structures in the second trimester assessment with 7.0-T MRI.,2012,Exvivo,2,lenticular nucleus,51,Segmentation,2,Manual,1,T2NAweighted,2,7.0,1,2,7,69,NA,NA,NA,NA,0.23,0.23,0.5,0.02645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
103,Meng,Development of the subcortical brain structures in the second trimester assessment with 7.0-T MRI.,2012,Exvivo,2,dorsal thalamus,120,Segmentation,2,Manual,1,T2NAweighted,2,7.0,1,2,7,69,NA,NA,NA,NA,0.23,0.23,0.5,0.02645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
104,Mestres_Misse,Dorsomedial striatum involvement in regulating conflict between current and presumed outcomes.,2014,Invivo,1,striatum,16,Segmentation,2,SemiNAautomatic,3,T1NAweighted,1,7.0,1,1,0,23,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
105,Miller,Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry the BIOCARD cohort.,2015,Invivo,1,amygdala,3,Segmentation,2,Manual,1,T1NAweighted,1,7.0,1,1,0,1,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
106,Mitsumori,Toward Understanding Transverse Relaxation in Human Brain Through Its Field Dependence.,2012,invivo,1,globus pallidus,13,Segmentation,2,Manual VOI within visual identified region,2,T2*NAmaps,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,1,2,2.5,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
106,Mitsumori,Toward Understanding Transverse Relaxation in Human Brain Through Its Field Dependence.,2012,invivo,1,caudate,17,Segmentation,2,Manual VOI within visual identified region,2,T2*NAmaps,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,1,2,2.5,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
106,Mitsumori,Toward Understanding Transverse Relaxation in Human Brain Through Its Field Dependence.,2012,invivo,1,putamen,19,Segmentation,2,Manual VOI within visual identified region,2,T2*NAmaps,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,1,2,2.5,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
106,Mitsumori,Toward Understanding Transverse Relaxation in Human Brain Through Its Field Dependence.,2012,invivo,1,thalamus,115,Segmentation,2,Manual VOI within visual identified region,2,T2*NAmaps,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,1,2,2.5,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
107,Moenninghoff,Assessing a dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) with 7T MR imaging.,2014,Invivo,1,dentate nucleus,25,Identification,1,NA,0,SWI,6,7.0,1,3,8,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,3,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
108,Moerel,Processing of frequency and location in human subcortical auditory structures,2015,Invivo,1,lateral geniculate thalamic nucleus,129,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,6,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
108,Moerel,Processing of frequency and location in human subcortical auditory structures,2015,Invivo,1,medial geniculate thalamic nucleus,133,Segmentation,2,Manual,1,T1 MPRAGE,1,7.0,1,1,0,6,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
109,Mollink,Dentatorubrothalamic tract localization with postmortem MR diffusion tractography compared to histological 3D reconstruction.,2015,Exvivo,2,dentate nucleus,25,Segmentation,2,Manual,1,TRUFI,2,7.0,1,1,0,1,NA,NA,NA,NA,0.4,0.4,0.5,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
109,Mollink,Dentatorubrothalamic tract localization with postmortem MR diffusion tractography compared to histological 3D reconstruction.,2015,Exvivo,2,thalamus,115,Segmentation,2,Manual,1,TRUFI,2,7.0,1,1,0,1,NA,NA,NA,NA,0.4,0.4,0.5,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,inferior colliculus,47,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,superior colliculus,48,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,oculomotor nucleus,64,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,periaqueductal gray,68,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,pons,79,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,upper pons,80,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,middle pons,81,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,lower pons,82,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,red nucleus,91,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110,Novak,High resolution MRI of the brainstem at 8 T.,2001,Invivo,1,substantia nigra,104,Identification,1,NA,0,T2* GRE,3,8.0,2,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
111,Novak ,Intracranial ossifications and microangiopathy at 8 Tesla MRI,2001,Invivo,1,globus pallidus,13,Identification,1,NA,0,GRE,3,8.0,2,3,8,17,NA,NA,NA,NA,NA,NA,NA,NA,0.396,0.396,2,0.313632,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
111,Novak ,Intracranial ossifications and microangiopathy at 8 Tesla MRI,2001,Invivo,1,caudate,17,Identification,1,NA,0,GRE,3,8.0,2,3,8,17,NA,NA,NA,NA,NA,NA,NA,NA,0.396,0.396,2,0.313632,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
112,O'Brain,Robust T1-Weighted Structural Brain Imaging and Morphometry at 7T Using MP2RAGE.,2014,Invivo,1,brain stem,10,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,1,1,1.2,1.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
112,O'Brain,Robust T1-Weighted Structural Brain Imaging and Morphometry at 7T Using MP2RAGE.,2014,Invivo,1,pituary gland ,75,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,1,1,1.2,1.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
113,Zeineh,Ultrahigh-Resolution Imaging of the Human Brain with Phase-Cycled Balanced Steady-State Free Precession at 7 T.,2014,Invivo,1,red nucleus,91,Segmentation,2,Manual VOI within visual identified region,2,bSSFP,9,7.0,1,3,5,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064
113,Zeineh,Ultrahigh-Resolution Imaging of the Human Brain with Phase-Cycled Balanced Steady-State Free Precession at 7 T.,2014,Invivo,1,substantia nigra,104,Identification,1,NA,0,bSSFP,9,7.0,1,3,5,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064
113,Zeineh,Ultrahigh-Resolution Imaging of the Human Brain with Phase-Cycled Balanced Steady-State Free Precession at 7 T.,2014,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,bSSFP,9,7.0,1,3,5,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.4,0.064
114,Plantinga,Ultra-high field MRI post mortem structural connectiviy of the human subthalamic nucleus substantia nigra and globus pallidus,2016,Exvivo,2,subthalamic nucleus,112,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114,Plantinga,Ultra-high field MRI post mortem structural connectiviy of the human subthalamic nucleus substantia nigra and globus pallidus,2016,Exvivo,2,substantia nigra pars compacta,105,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114,Plantinga,Ultra-high field MRI post mortem structural connectiviy of the human subthalamic nucleus substantia nigra and globus pallidus,2016,Exvivo,2,substantia nigra pars reticularis,110,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114,Plantinga,Ultra-high field MRI post mortem structural connectiviy of the human subthalamic nucleus substantia nigra and globus pallidus,2016,Exvivo,2,globus pallidus internal segment,14,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114,Plantinga,Ultra-high field MRI post mortem structural connectiviy of the human subthalamic nucleus substantia nigra and globus pallidus,2016,Exvivo,2,globus pallidus external segment,15,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.3,0.3,0.3,0.027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
115,Plantinga,Individualized parcellation of the subthalamic nucleus in patients with parkinsons disease with 7T mri,2017,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,T2 SE,2,7.0,1,2,1,17,NA,NA,NA,NA,0.39,1,0.39,0.1521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
116,Peters,T2* measurements in human brain at 1.5. 3 and 7 T.pdf,2007,Invivo,1,caudate,17,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,2.11,2.11,3,13.3563,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
116,Peters,T2* measurements in human brain at 1.5. 3 and 7 T.pdf,2007,Invivo,1,putamen,19,Segmentation,2,Manual,1,T2*,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,2.11,2.11,3,13.3563,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,superior colliculus,48,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,periaqueductal gray,68,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,red nucleus,91,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,substantia nigra,104,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,subthalamic nucleus,112,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,lateral geniculate thalamic nucleus,129,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,medial geniculate thalamic nucleus,133,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,pulvinar,136,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117,Rijkers,The microanatomical environment of the subthalamic nucleus. Technical note.,2007,Exvivo,2,zona incerta,151,Identification,1,NA,0,T2 SE,2,9.4,3,9999,9999,1,NA,NA,NA,NA,0.1,0.1,1,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
118,Robitaille,RF Penetration in Ultra High Field MRI Challenges in Visualizing Details Within the Center of the Human Brain.,1999,Invivo,1,mammillary body,53,Identification,1,NA,0,GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
118,Robitaille,RF Penetration in Ultra High Field MRI Challenges in Visualizing Details Within the Center of the Human Brain.,1999,Invivo,1,pineal gland,71,Identification,1,NA,0,GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
118,Robitaille,RF Penetration in Ultra High Field MRI Challenges in Visualizing Details Within the Center of the Human Brain.,1999,Invivo,1,red nucleus,91,Identification,1,NA,0,GRE,3,8.0,2,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.195,0.195,2,0.07605,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
119,Romanzetti,Mapping tissue sodium concentration in the human brain a comparison of MR sequences at 9.4Tesla.,2014,Invivo,1,thalamus,115,Identification,1,NA,0,Tissue Sodium concetration map based on DAR,9,9.4,3,1,0,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3,3,27
120,Rooney,Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo.,2007,Invivo,1,globus pallidus,13,Segmentation,2,Manual VOI within visual identified region,2,PURR,1,7.0,1,1,0,3,1.5,1.5,5,11.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
120,Rooney,Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo.,2007,Invivo,1,caudate,17,Segmentation,2,Manual VOI within visual identified region,2,PURR,1,7.0,1,1,0,3,1.5,1.5,5,11.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
120,Rooney,Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo.,2007,Invivo,1,putamen,19,Segmentation,2,Manual VOI within visual identified region,2,PURR,1,7.0,1,1,0,3,1.5,1.5,5,11.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
120,Rooney,Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo.,2007,Invivo,1,thalamus,115,Segmentation,2,Manual VOI within visual identified region,2,PURR,1,7.0,1,1,0,3,1.5,1.5,5,11.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
121,Rotte,Feasibility of high-resolution pituitary MRI at 7.,2014,Invivo,1,anterior pituitary gland,72,Identification,1,NA,0,T1NAweighted and T2NAweighted TSE,10,7.0,1,3,8,15,0.8,0.8,0.8,0.512,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
121,Rotte,Feasibility of high-resolution pituitary MRI at 7.,2014,Invivo,1,posterior pituitary gland,73,Identification,1,NA,0,T1NAweighted and T2NAweighted TSE,10,7.0,1,3,8,15,0.8,0.8,0.8,0.512,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
121,Rotte,Feasibility of high-resolution pituitary MRI at 7.,2014,Invivo,1,pituitary stalk,74,Identification,1,NA,0,T1NAweighted and T2NAweighted TSE,10,7.0,1,3,8,15,0.8,0.8,0.8,0.512,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
122,Rotte,High resolution pituitary gland MRI at 7.0 tesla a clinical evaluation in Cushing's disease.,2015,Invivo,1,pituary gland ,75,Identification,1,NA,0,T1NAweighted and T2NAweighted TSE,10,7.0,1,2,8,16,0.8,0.8,0.8,0.512,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
123,Rudko,Multiple sclerosis improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.,2014,Invivo,1,globus pallidus,13,Segmentation,2,Automatic (FIRST),4,T1NAweighted,1,7.0,1,3,2,40,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
123,Rudko,Multiple sclerosis improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.,2014,Invivo,1,caudate,17,Segmentation,2,Automatic (FIRST),4,T1NAweighted,1,7.0,1,3,2,40,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
123,Rudko,Multiple sclerosis improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.,2014,Invivo,1,putamen,19,Segmentation,2,Automatic (FIRST),4,T1NAweighted,1,7.0,1,3,2,40,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
123,Rudko,Multiple sclerosis improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.,2014,Invivo,1,thalamus,115,Segmentation,2,Automatic (FIRST),4,T1NAweighted,1,7.0,1,3,2,40,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
124,Satpute,Identification of discrete functional subregions of the human periaqueductal gray.,2013,Invivo,1,periaqueductal gray,68,Segmentation,2,Manual,1,T2* EPI,4,7.0,1,1,0,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,0.75,0.75,0.421875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
125,Schafer,Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping.,2011,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,SWI,6,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
125,Schafer,Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping.,2011,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,SWI,6,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
125,Schafer,Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping.,2011,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,SWI,6,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
126,Schafer,Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI.,2009,Invivo,1,red nucleus,91,Segmentation,2,Manual (slice),2,T2* magnitude,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
126,Schafer,Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI.,2009,Invivo,1,substantia nigra,104,Segmentation,2,Manual (slice),2,T2* magnitude,3,7.0,1,1,0,9999,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,globus pallidus internal segment,14,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,h2 field of forel,34,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,hypothalamus,41,Segmentation,2,Manual,1,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,mammillary body,53,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,olfactory area,65,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,substantia nigra,104,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,subthalamic nucleus,112,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,thalamus,115,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127,Schindler,Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance images.,2013,Invivo,1,zona incerta,151,Identification,1,NA,0,T1 MP2RAGE,1,7.0,1,1,0,10,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
128,Schindler,Intensity standardisation of 7T mr images for intensity-based segmentation of the human hypothalamus,2017,Invivo,1,hypothalamus,41,Segmentation,2,Manual,1,T1 MP2RAGE,1,7.0,1,1,0,84,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
129,Schmidt,Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI,2017,Invivo,1,habenula,35,Segmentation,2,Manual,1,T1 maps MP2RAGE,1,7.0,1,3,8,60,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
130,Schmidt,UHF SWI of the substantia nigra at 7t- reliability and consistency of the swallow-tail sign,2017,Invivo,1,nigrosome,152,Identification,1,NA,0,SWI,6,7.0,1,1,0,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,accumbens area,2,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,amygdala,3,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,brain stem,10,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,globus pallidus,13,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,caudate,17,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,putamen,19,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,choroid plexus,22,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131,Schreiner,Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.,2014,Invivo,1,thalamus,115,Segmentation,2,Automatic (freesurfer),4,T1NAMPRAGE,1,7.0,1,1,0,14,0.86,0.61,1.14,0.598044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132,Shmueli,Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data.,2009,Invivo,1,putamen,19,Segmentation,2,Manual,1,R2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132,Shmueli,Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data.,2009,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,R2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132,Shmueli,Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data.,2009,Invivo,1,substantia nigra,104,Segmentation,2,Manual,1,R2*,3,7.0,1,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
133,Sladky,High-resolution functional MRI of the human amygdala at 7 T.pdf,2013,Invivo,1,amygdala,3,Segmentation,2,n.s.,9999,T2* EPI,4,7.0,1,1,0,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,2,4.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134,Solano_Castiella,Parcellation of human amygdala in vivo using ultra high field structural MRI.,2011,Invivo,1,amygdala,3,Segmentation,2,Manual,1,T1NAweighted,1,7.0,1,1,0,9,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134,Solano_Castiella,Parcellation of human amygdala in vivo using ultra high field structural MRI.,2011,Invivo,1,basolateral amygdala,4,Segmentation,2,Automatic (intensity KNAmeans ),4,T2 and T2*,10,7.0,1,1,0,9,NA,NA,NA,NA,1.2,1.2,1.2,1.728,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134,Solano_Castiella,Parcellation of human amygdala in vivo using ultra high field structural MRI.,2011,Invivo,1,centromedial amygdala,6,Segmentation,2,Automatic (intensity KNAmeans ),4,T2 and T2*,10,7.0,1,1,0,9,NA,NA,NA,NA,1.2,1.2,1.2,1.728,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134,Solano_Castiella,Parcellation of human amygdala in vivo using ultra high field structural MRI.,2011,Invivo,1,superficial amygdala,8,Segmentation,2,Automatic (intensity KNAmeans ),4,T2 and T2*,10,7.0,1,1,0,9,NA,NA,NA,NA,1.2,1.2,1.2,1.728,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134,Solano_Castiella,Parcellation of human amygdala in vivo using ultra high field structural MRI.,2011,Invivo,1,anterior perforated substance amygdala,9,Identification,1,NA,0,T1NAweighted,1,7.0,1,1,0,9,1.2,1.2,1.2,1.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
135,Solbach,Cerebellar pathology in Friedreich's ataxia atrophied dentate nuclei with normal iron content.,2014,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,Phase image,3,7.0,1,3,6,28,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,2,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,abducens nucleus,1,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,dorsal accessory olivary nucleus,26,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,dorsal cochlear nucleus,27,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,dorsal motor nucleus of the vagus,28,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,facial motor nucleus,30,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,hypoglossal nucleus,40,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,inferior colliculus,47,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,inferior olivary nucleus,49,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,medial accessory olivary nucleus,54,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,cuneatus nucleus,58,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,gracil nucleus,60,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,solitary nucleus,63,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,periaqueductal gray,68,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,principal sensory and motor trigeminal nuclei,78,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,pontine nuclei,83,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,red nucleus,91,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,spinal nucleus of the accessory nerve,99,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,spinal olivary nucleus,100,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,spinal nucleus of the trigeminal nerve,101,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,substantia nigra pars compacta,105,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,substantia nigra pars reticularis,110,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,vestibular nuclei,149,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136,Soria,Improved assessment of ex vivo brainstem neuroanatomy with high-resolution MRI and DTI at 7 Tesla.,2011,Exvivo,2,ventral tegmental area,150,Identification,1,NA,0,T1NAweighted and DTI ,10,7.0,1,1,0,3,0.15,0.15,0.6,0.0135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.4,0.6,0.096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
137,Stefanescu ,A 7T fMRI study of cerebellar activation in sequential finger movement tasks.,2013,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,mean functional EPI,4,7.0,1,1,0,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,1.9,7.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
138,Stefanescu ,Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3. SCA6 and Friedreich's ataxia.,2015,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,3D SWI 2nd echo,6,7.0,1,3,6,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
139,Strotmann,Mapping of the internal structure of human habenula with ex vivo MRI at 7T.,2013,Exvivo,2,lateral habenula,36,Identification,1,NA,0,T1 and T2* maps,10,7.0,1,1,0,1,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.06,0.06,0.06,0.000216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
139,Strotmann,Mapping of the internal structure of human habenula with ex vivo MRI at 7T.,2013,Exvivo,2,lateral habenula lateral part,37,Identification,1,NA,0,T1 and T2* maps,10,7.0,1,1,0,1,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.06,0.06,0.06,0.000216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
139,Strotmann,Mapping of the internal structure of human habenula with ex vivo MRI at 7T.,2013,Exvivo,2,lateral habenula medial part,38,Identification,1,NA,0,T1 and T2* maps,10,7.0,1,1,0,1,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.06,0.06,0.06,0.000216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
139,Strotmann,Mapping of the internal structure of human habenula with ex vivo MRI at 7T.,2013,Exvivo,2,medial habenula,39,Identification,1,NA,0,T1 and T2* maps,10,7.0,1,1,0,1,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.06,0.06,0.06,0.000216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
140,Strotmann,High-resolution MRI and diffusion-weighted imaging of the human habenula at 7 tesla.,2014,Invivo,1,habenula,35,Identification,1,NA,0,T1. T2* and PD (& DWI for exvivo),10,7.0,1,1,0,3,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA
140,Strotmann,High-resolution MRI and diffusion-weighted imaging of the human habenula at 7 tesla.,2014,Exvivo,2,habenula,35,Identification,1,NA,0,T1. T2* and PD (& DWI for exvivo),10,7.0,1,1,0,1,0.15,0.15,0.15,0.003375,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA
140,Strotmann,High-resolution MRI and diffusion-weighted imaging of the human habenula at 7 tesla.,2014,Invivo,1,lateral habenula,36,Identification,1,NA,0,T1. T2* and PD (& DWI for exvivo),10,7.0,1,1,0,3,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA
140,Strotmann,High-resolution MRI and diffusion-weighted imaging of the human habenula at 7 tesla.,2014,Exvivo,2,lateral habenula,36,Identification,1,NA,0,T1. T2* and PD (& DWI for exvivo),10,7.0,1,1,0,1,0.15,0.15,0.15,0.003375,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA
140,Strotmann,High-resolution MRI and diffusion-weighted imaging of the human habenula at 7 tesla.,2014,Invivo,1,medial habenula,39,Identification,1,NA,0,T1. T2* and PD (& DWI for exvivo),10,7.0,1,1,0,3,0.3,0.3,0.3,0.027,NA,NA,NA,NA,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA
140,Strotmann,High-resolution MRI and diffusion-weighted imaging of the human habenula at 7 tesla.,2014,Exvivo,2,medial habenula,39,Identification,1,NA,0,T1. T2* and PD (& DWI for exvivo),10,7.0,1,1,0,1,0.15,0.15,0.15,0.003375,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,0.25,0.25,0.25,0.015625,NA,NA,NA,NA
141,Stuber,Myelin and iron concentration in the human brain a quantitative study of MRI contrast.,2014,Exvivo,2,substantia nigra,104,Identification,1,NA,0,T2*,3,7.0,1,9999,9999,1,NA,NA,NA,NA,NA,NA,NA,NA,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
141,Stuber,Myelin and iron concentration in the human brain a quantitative study of MRI contrast.,2014,Exvivo,2,subthalamic nucleus,112,Segmentation,2,Manual (single slice?),2,T2*,3,7.0,1,9999,9999,1,NA,NA,NA,NA,NA,NA,NA,NA,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
142,Tang,Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease detecting. quantifying. and predicting.,2014,Invivo,1,basolateral amygdala,4,Segmentation,2,Manual,1,T1NAweighted,1,7.0,1,1,0,1,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
142,Tang,Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease detecting. quantifying. and predicting.,2014,Invivo,1,basomedial amygdala,5,Segmentation,2,Manual,1,T1NAweighted,1,7.0,1,1,0,1,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
142,Tang,Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease detecting. quantifying. and predicting.,2014,Invivo,1,centromedial amygdala,6,Segmentation,2,Manual,1,T1NAweighted,1,7.0,1,1,0,1,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
142,Tang,Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease detecting. quantifying. and predicting.,2014,Invivo,1,lateral nucleus amygdala,7,Segmentation,2,Manual,1,T1NAweighted,1,7.0,1,1,0,1,0.8,0.8,0.8,0.512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
143,Thayyil,Post-mortem examination of human fetuses_ a comparison of whole-body high-field MRI at 94 T with conventional MRI and invasive autopsy.,2009,Exvivo,2,thalamus,115,Identification,1,NA,0,T2NAweighted ,2,9.4,3,2,7,17,0.2,0.2,0.2,0.008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
144,Thomas,High-Resolution 7T MRI of the Human Hippocampus In Vivo,2008,Invivo,1,amygdala,3,Identification,1,NA,0,T2*NAweighted,3,7.0,1,1,0,6,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,2.5,0.625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
145,Thulborn,Quantitative sodium MRI of the human brain at 9.4T provides assessment of tissue sodium concentration and cell volume fraction during normal aging.,2014,Invivo,1,brain stem,10,Segmentation,2,Manual VOI within visual identified region,2,quantitiatve Sodium images,9,9.4,3,1,0,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.5,3.5,3.5,42.875
145,Thulborn,Quantitative sodium MRI of the human brain at 9.4T provides assessment of tissue sodium concentration and cell volume fraction during normal aging.,2014,Invivo,1,basal ganglia,12,Segmentation,2,Manual VOI within visual identified region,2,quantitiatve Sodium images,9,9.4,3,1,0,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.5,3.5,3.5,42.875
145,Thulborn,Quantitative sodium MRI of the human brain at 9.4T provides assessment of tissue sodium concentration and cell volume fraction during normal aging.,2014,Invivo,1,thalamus,115,Segmentation,2,Manual VOI within visual identified region,2,quantitiatve Sodium images,9,9.4,3,1,0,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.5,3.5,3.5,42.875
146,Thurling,Activation of the dentate nucleus in a verb generation task A 7T MRI study.,2011,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,mean functional EPI,4,7.0,1,1,0,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,1.9,7.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
147,Thurling,Involvement of the cerebellar cortex and nuclei in verbal and visuospatial working memory a 7 T fMRI study.,2012,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,mean functional EPI,4,7.0,1,1,0,44,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,1.9,7.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
148,Thurling,Cerebellar cortex and cerebellar nuclei are concomitantly activated during eyeblink conditioning a 7T fMRI study in humans.,2015,Invivo,1,interposed nucleus,20,Segmentation,2,Manual,1,SWI,6,7.0,1,1,0,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
148,Thurling,Cerebellar cortex and cerebellar nuclei are concomitantly activated during eyeblink conditioning a 7T fMRI study in humans.,2015,Invivo,1,dentate nucleus,25,Segmentation,2,Manual,1,SWI,6,7.0,1,1,0,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,habenula,35,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,subthalamic nucleus,112,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,centromedian thalamic nucleus,119,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,medial dorsal thalamic nucleus,121,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,lateral dorsal thalamic nucleus,127,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,lateral geniculate thalamic nucleus,129,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,medial geniculate thalamic nucleus,133,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,pulvinar,136,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,ventral anterior thalamic nucleus,138,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,ventral lateral anterior thalamic nucleus,141,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,ventral lateral posterior thalamic nucleus,142,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,Tourdias,Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.,2014,Invivo,1,ventral posterior thalamic nucleus,144,Segmentation,2,Manual,1,Optimized whiteNAmatterNAnulled MPRAGE,1,7.0,1,1,0,6,0.7,0.7,0.5,0.245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
150,Trampel,Anatomical Brain Imaging at 7T Using Two-Dimensional GRASE.,2014,Invivo,1,basal ganglia,12,Identification,1,NA,0,GRASE,2,7.0,1,9999,9999,9999,NA,NA,NA,NA,0.5,0.5,0.6,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Invivo,1,globus pallidus,13,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Invivo,1,putamen,19,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Invivo,1,red nucleus,91,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Invivo,1,substantia nigra,104,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Exvivo,2,globus pallidus,13,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,4,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Exvivo,2,putamen,19,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,4,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Exvivo,2,red nucleus,91,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,4,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151,Truong,Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 str measurements with macroscopic B0 inhomogeneity compensation.,2006,Exvivo,2,substantia nigra,104,Segmentation,2,n.s.,9999,bmGESEPI T2* map,3,8.0,2,3,8,4,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,3,1.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
152,Van Bergen,QSM suggests altered brain iron in premanifest hd,2016,Invivo,1,substantia nigra,104,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,3,3,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
152,Van Bergen,QSM suggests altered brain iron in premanifest hd,2016,Invivo,1,red nucleus,91,Segmentation,2,Semi automatic,3,QSM,6,7.0,1,3,3,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
153,van den Boogard,Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism,2011,Invivo,1,caudate,17,Segmentation,2,Manual VOI within visual identified region,2,3D T1 GRE,1,7.0,1,3,3,44,0.44,0.44,0.84,0.162624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
153,van den Boogard,Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism,2011,Invivo,1,putamen,19,Segmentation,2,Manual VOI within visual identified region,2,3D T1 GRE,1,7.0,1,3,3,44,0.44,0.44,0.84,0.162624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
153,van den Boogard,Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism,2011,Invivo,1,hypothalamus,41,Segmentation,2,Manual VOI within visual identified region,2,3D T1 GRE,1,7.0,1,3,3,44,0.44,0.44,0.84,0.162624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
153,van den Boogard,Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism,2011,Invivo,1,thalamus,115,Segmentation,2,Manual VOI within visual identified region,2,3D T1 GRE,1,7.0,1,3,3,44,0.44,0.44,0.84,0.162624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
154,Verma,Implementation of two-dimensional L-COSY at 7 Tesla an investigation of reproducibility in human brain.,2014,Invivo,1,basal ganglia,12,Segmentation,2,Manual VOI within visual identified region,2,MPRAGE,1,7.0,1,1,0,2,9999,9999,9999,9999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
155,Visser,Automatic segmentation of the striatum and globus pallidus using MIST/ Multimodal Image Segmentation Tool.,2015,invivo,1,globus pallidus,13,Segmentation,2,Automatic (MIST),4,T1. T2* and QSM combined,10,7.0,1,1,0,54,0.7,0.7,0.7,0.343,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
155,Visser,Automatic segmentation of the striatum and globus pallidus using MIST/ Multimodal Image Segmentation Tool.,2015,invivo,1,caudate,17,Segmentation,2,Automatic (MIST),4,T1. T2* and QSM combined,10,7.0,1,1,0,54,0.7,0.7,0.7,0.343,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
155,Visser,Automatic segmentation of the striatum and globus pallidus using MIST/ Multimodal Image Segmentation Tool.,2015,invivo,1,putamen,19,Segmentation,2,Automatic (MIST),4,T1. T2* and QSM combined,10,7.0,1,1,0,54,0.7,0.7,0.7,0.343,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156,Visser,"Automated segmentation of the substantia nigra, subthalamic nucleus and red nucleus in 7T data at young and old age",2016,invivo,1,substantia nigra,104,Segmentation,2,Automatic (MIST),4,T1. T2* and QSM combined,10,7.0,1,1,0,54,0.7,0.7,0.7,0.343,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156,Visser,"Automated segmentation of the substantia nigra, subthalamic nucleus and red nucleus in 7T data at young and old age",2016,invivo,1,subthalamic nucleus,112,Segmentation,2,Automatic (MIST),4,T1. T2* and QSM combined,10,7.0,1,1,0,54,0.7,0.7,0.7,0.343,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156,Visser,"Automated segmentation of the substantia nigra, subthalamic nucleus and red nucleus in 7T data at young and old age",2016,invivo,1,red nucleus,91,Segmentation,2,Automatic (MIST),4,T1. T2* and QSM combined,10,7.0,1,1,0,54,0.7,0.7,0.7,0.343,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
157,Wang,Assessment of age-related morphometric changes of subcortical structures in healthy people using uhf 7T mri,2016,invivo,1,central lateral nucleus,158,Identification,1,NA,0,T1,1,7.0,1,1,0,53,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158,Wargo,Localized high-resolution DTI of the human midbrain using single-shot EPI. parallel imaging. and outer-volume suppression at 7T.,2013,Invivo,1,putamen,19,Segmentation,2,Manual,1,OuterNAvolume suppresion DTI,5,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158,Wargo,Localized high-resolution DTI of the human midbrain using single-shot EPI. parallel imaging. and outer-volume suppression at 7T.,2013,Invivo,1,pons,79,Segmentation,2,Manual,1,OuterNAvolume suppresion DTI,5,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158,Wargo,Localized high-resolution DTI of the human midbrain using single-shot EPI. parallel imaging. and outer-volume suppression at 7T.,2013,Invivo,1,red nucleus,91,Segmentation,2,Manual,1,OuterNAvolume suppresion DTI,5,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158,Wargo,Localized high-resolution DTI of the human midbrain using single-shot EPI. parallel imaging. and outer-volume suppression at 7T.,2013,Invivo,1,thalamus,115,Segmentation,2,Manual,1,OuterNAvolume suppresion DTI,5,7.0,1,1,0,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
159,Weiss,Spatial normalization of ultrahigh resolution 7 T magnetic resonance imaging data of the postmortem human subthalamic nucleus a multistage approach.,2015,Exvivo,2,subthalamic nucleus,112,Segmentation,2,Manual,1,T2* GRE ,3,7.0,1,1,0,4,NA,NA,NA,NA,NA,NA,NA,NA,0.1,0.1,0.1,0.001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
160,Wharton,Susceptibility Mapping in the Human Brain Using Threshold-Based k-Space Division.,2010,Invivo,1,red nucleus,91,Segmentation,2,Manual VOI within visual identified region,2,Susceptibility maps,6,7.0,1,1,0,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
160,Wharton,Susceptibility Mapping in the Human Brain Using Threshold-Based k-Space Division.,2010,Invivo,1,substantia nigra,104,Segmentation,2,Manual VOI within visual identified region,2,Susceptibility maps,6,7.0,1,1,0,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.5,0.5,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
161,Wharton,Whole-brain susceptibility mapping at high field A comparison of multiple- and single-orientation methods.,2010,Invivo,1,globus pallidus,13,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
161,Wharton,Whole-brain susceptibility mapping at high field A comparison of multiple- and single-orientation methods.,2010,Invivo,1,caudate,17,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
161,Wharton,Whole-brain susceptibility mapping at high field A comparison of multiple- and single-orientation methods.,2010,Invivo,1,putamen,19,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
161,Wharton,Whole-brain susceptibility mapping at high field A comparison of multiple- and single-orientation methods.,2010,Invivo,1,red nucleus,91,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
161,Wharton,Whole-brain susceptibility mapping at high field A comparison of multiple- and single-orientation methods.,2010,Invivo,1,substantia nigra,104,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
161,Wharton,Whole-brain susceptibility mapping at high field A comparison of multiple- and single-orientation methods.,2010,Invivo,1,thalamus,115,Segmentation,2,Manual   ,1,Susceptibility maps,6,7.0,1,1,0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
162,Wright,Water proton T1 measurements in brain tissue at 7. 3. and 1.5 T using IR-EPI. IR-TSE. and MPRAGE results and optimization.,2008,Invivo,1,caudate,17,Segmentation,2,Manual VOI within visual identified region,2,T1NAweighted,1,7.0,1,1,0,4,0.86,0.86,1.5,11.094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
162,Wright,Water proton T1 measurements in brain tissue at 7. 3. and 1.5 T using IR-EPI. IR-TSE. and MPRAGE results and optimization.,2008,Invivo,1,putamen,19,Segmentation,2,Manual VOI within visual identified region,2,T1NAweighted,1,7.0,1,1,0,4,0.86,0.86,1.5,11.094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
163,Yang,Integration of ultra-high field MRI and histology for connectome based research of brain disorders.,2013,Exvivo,2,dentate nucleus,25,Identification,1,NA,0,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.15,0.15,0.15,0.003375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Invivo,1,globus pallidus,13,Segmentation,2,Manual,1,T1NAweighted MPRAGE,1,7.0,1,1,0,9,0.94,0.94,1,0.8836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Invivo,1,caudate,17,Segmentation,2,Manual,1,T1NAweighted MPRAGE,1,7.0,1,1,0,9,0.94,0.94,1,0.8836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Invivo,1,putamen,19,Segmentation,2,Manual,1,T1NAweighted MPRAGE,1,7.0,1,1,0,9,0.94,0.94,1,0.8836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Invivo,1,thalamus,115,Segmentation,2,Manual,1,T1NAweighted MPRAGE,1,7.0,1,1,0,9,0.94,0.94,1,0.8836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Exvivo,2,globus pallidus,13,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,9,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Exvivo,2,caudate,17,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Exvivo,2,putamen,19,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164,Yao,Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.,2009,Exvivo,2,thalamus,115,Segmentation,2,Manual,1,T2*NAweighted,3,7.0,1,1,0,2,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.7,0.7,0.343,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
165,Zhang,Development of fetal brain of 20 weeks gestational age assessment with postmortem Magnetic Resonance Imaging.,2011,Exvivo,2,caudate,17,Segmentation,2,Manual,1,T2NAweighted ,2,7.0,1,2,7,20,NA,NA,NA,NA,0.234,0.234,0.5,0.027378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
165,Zhang,Development of fetal brain of 20 weeks gestational age assessment with postmortem Magnetic Resonance Imaging.,2011,Exvivo,2,lenticular nucleus,51,Segmentation,2,Manual,1,T2NAweighted ,2,7.0,1,2,7,20,NA,NA,NA,NA,0.234,0.234,0.5,0.027378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
165,Zhang,Development of fetal brain of 20 weeks gestational age assessment with postmortem Magnetic Resonance Imaging.,2011,Exvivo,2,dorsal thalamus,120,Segmentation,2,Manual,1,T2NAweighted ,2,7.0,1,2,7,20,NA,NA,NA,NA,0.234,0.234,0.5,0.027378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
166,Zielman,Biochemical changes in the brain of hemiplegic migraine patients measured with 7 tesla 1H-MRS.,2014,Invivo,1,hypothalamus,41,Segmentation,2,Manual VOI within visual identified region,2,T2NAweighted ,2,7.0,1,3,8,37,NA,NA,NA,NA,0.5,0.6,2.5,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
166,Zielman,Biochemical changes in the brain of hemiplegic migraine patients measured with 7 tesla 1H-MRS.,2014,Invivo,1,pons,79,Segmentation,2,Manual VOI within visual identified region,2,T2NAweighted ,2,7.0,1,3,8,37,NA,NA,NA,NA,0.5,0.6,2.5,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
167,Zrinzo,Targeting of the pedunculopontine nucleus by an MRI-guided approach a cadaver study.,2011,Exvivo,2,periaqueductal gray,68,Identification,1,NA,0,T2NAweighted ,2,9.4,3,1,0,1,NA,NA,NA,NA,0.195,0.195,1.2,0.038025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168,Zwanenburg,MR angiography of the cerebral perforating arteries with magnetization prepared anatomical reference at 7 T comparison with time-of-flight.,2008,Invivo,1,globus pallidus,13,Segmentation,2,Manual VOI within visual identified region,2,T1 MPARENAMRA,1,7.0,1,1,0,7,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168,Zwanenburg,MR angiography of the cerebral perforating arteries with magnetization prepared anatomical reference at 7 T comparison with time-of-flight.,2008,Invivo,1,head of the caudate nucleus,18,Segmentation,2,Manual VOI within visual identified region,2,T1 MPARENAMRA,1,7.0,1,1,0,7,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168,Zwanenburg,MR angiography of the cerebral perforating arteries with magnetization prepared anatomical reference at 7 T comparison with time-of-flight.,2008,Invivo,1,putamen,19,Segmentation,2,Manual VOI within visual identified region,2,T1 MPARENAMRA,1,7.0,1,1,0,7,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168,Zwanenburg,MR angiography of the cerebral perforating arteries with magnetization prepared anatomical reference at 7 T comparison with time-of-flight.,2008,Invivo,1,thalamus,115,Segmentation,2,Manual VOI within visual identified region,2,T1 MPARENAMRA,1,7.0,1,1,0,7,0.6,0.6,0.6,0.216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
169,Zwanenburg,Fluid attenuated inversion recovery (FLAIR) MRI at 7.0 Tesla comparison with 1.5 and 3.0 Tesla.,2010,invivo,1,subthalamic nucleus,112,Identification,1,NA,0,T2 FLAIR,2,7.0,1,1,0,5,NA,NA,NA,NA,0.65,0.88,4,2.288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA